Benjamin Hutzel - Extendicare Independent Chairman of the Board
| EXETFDelisted Stock | USD 5.00 0.00 0.00% |
Chairman
Mr. Benjamin J. Hutzel is Director of Extendicare Inc. Mr. Hutzel is a retired partner of Bennett Jones LLP where he had an extensive national and international legal practice specializing in financings, acquisitions and divestitures and joint venture structuring . Mr. Hutzel serves on the board of the Woodbine Entertainment Group, where he is also Chair of the Pension, Human Resources and Compensation Committee and a member of the Audit Committee, and was the former Chair of the Audit Committee. Formerly, Mr. Hutzel served on the board of MI Developments Inc., where he was Chair of the Corporationrationrate Governance and Compensation Committee. In addition, as a nominee of the Federal Liberal Government, Mr. Hutzel is a former director of the Greater Toronto Airports Authority, where he served as Chairman of the Compensation and Corporationrationrate Governance Committee and as a member of the Audit Committee, during which time the board oversaw a redevelopment of Toronto Pearson International Airport in excess of 4 billion since 2017.
| Age | 74 |
| Tenure | 7 years |
| Phone | 905 470 4000 |
| Web | https://www.extendicare.com |
Extendicare Management Efficiency
The company has return on total asset (ROA) of 0.1102 % which means that it generated a profit of $0.1102 on every $100 spent on assets. This is way below average. Extendicare's management efficiency ratios could be used to measure how well Extendicare manages its routine affairs as well as how well it operates its assets and liabilities.The company has accumulated 463.27 M in total debt with debt to equity ratio (D/E) of 2.85, implying the company greatly relies on financing operations through barrowing. Extendicare has a current ratio of 1.07, suggesting that it is not liquid enough and may have problems paying out its financial obligations in time and when they become due. Debt can assist Extendicare until it has trouble settling it off, either with new capital or with free cash flow. So, Extendicare's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Extendicare sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Extendicare to invest in growth at high rates of return. When we think about Extendicare's use of debt, we should always consider it together with cash and equity.
Similar Executives
| Showing other executives | CHAIRMAN Age | ||
| Bruce Shear | Acadia Healthcare | 62 | |
| Dieter Schenk | Fresenius SE Co | 65 | |
| Ronald LaBorde | Amedisys | 58 | |
| Mark Heaney | Addus HomeCare | 58 | |
| Peter Evans | Ramsay Health Care | N/A | |
| Seymour Temkin | Medical Facilities | 75 | |
| Thomas Dircks | Cross Country Healthcare | 59 | |
| Christopher Laitala | Surgery Partners | 42 | |
| Michael Siddle | Ramsay Health Care | N/A | |
| Wayne DeVeydt | Surgery Partners | 54 | |
| Ulf Schneider | Fresenius SE Co | 49 | |
| Niko Stumpfoegger | Fresenius SE Co | 62 | |
| Donald Washburn | Amedisys | 73 | |
| Gerd Krick | Fresenius SE Co | 79 | |
| Joey Jacobs | Acadia Healthcare | 63 | |
Management Performance
| Return On Equity | 0.0018 | ||||
| Return On Asset | 0.11 |
Extendicare Leadership Team
Elected by the shareholders, the Extendicare's board of directors comprises two types of representatives: Extendicare inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Extendicare. The board's role is to monitor Extendicare's management team and ensure that shareholders' interests are well served. Extendicare's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Extendicare's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Ali Mir, ParaMed VP | ||
| Paul Tuttle, President of Extendicare (Canada) Inc | ||
| Samir Manji, Independent Director | ||
| Timothy Lukenda, CEO and President Non-Independent Director, Chairman of Extendicare (Canada) Inc, Chairman of Extendicare Health Services Inc, CEO of Extendicare (Canada) Inc and CEO of Extendicare Health Services Inc | ||
| Frederic Waks, Vice Chairman of the Board | ||
| Gary Loder, Vice President - Extendicare Assist and SGP Purchasing Partner Network (SGP) of ECI | ||
| MBA MD, Pres CEO | ||
| Jillian Fountain, Corporate Secretary | ||
| John Angus, Independent Director | ||
| Bruce Wienberg, VP Care | ||
| Elaine Everson, CFO and VP | ||
| Margery Cunningham, Independent Director | ||
| Sandra Hanington, Director | ||
| Lisa Pearson, VP Affairs | ||
| Alan Hibben, Director | ||
| David Bacon, CFO, Senior Vice President | ||
| Matthew Morgan, Chief Officer | ||
| Leslie Sarauer, VP Officer | ||
| Donna Kingelin, Director | ||
| Deborah Bakti, VP of HR and Silver Group Purchasing | ||
| Gail Paech, Director | ||
| Michael Harris, Vice President LTC Operations of ECI | ||
| Howard Dean, Independent Director | ||
| Benjamin Hutzel, Independent Chairman of the Board | ||
| Alan Torrie, Director | ||
| Michael Guerriere, Director | ||
| BRANDON PARENT, Vice President General Counsel | ||
| Norma Beauchamp, Independent Director | ||
| John Toffoletto, Chief VP | ||
| Steve Paraskevopoulos, VP CTO | ||
| Aladin Mawani, Director |
Extendicare Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Extendicare a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.0018 | ||||
| Return On Asset | 0.11 | ||||
| Profit Margin | 0.05 % | ||||
| Operating Margin | 0.12 % | ||||
| Current Valuation | 556.43 M | ||||
| Shares Outstanding | 83.94 M | ||||
| Shares Owned By Insiders | 13.15 % | ||||
| Shares Owned By Institutions | 17.61 % | ||||
| Price To Earning | 500.00 X | ||||
| Price To Book | 4.28 X |
Pair Trading with Extendicare
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Extendicare position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Extendicare will appreciate offsetting losses from the drop in the long position's value.Moving against Extendicare Pink Sheet
| 0.59 | NLY-PG | Annaly Capital Management | PairCorr |
| 0.59 | IVR-PB | Invesco Mortgage Capital | PairCorr |
| 0.48 | MITT-PB | AG Mortgage Investment | PairCorr |
| 0.48 | IVR-PC | Invesco Mortgage Capital | PairCorr |
| 0.47 | NLY-PF | Annaly Capital Management | PairCorr |
The ability to find closely correlated positions to Extendicare could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Extendicare when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Extendicare - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Extendicare to buy it.
The correlation of Extendicare is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Extendicare moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Extendicare moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Extendicare can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate. You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.
Other Consideration for investing in Extendicare Pink Sheet
If you are still planning to invest in Extendicare check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Extendicare's history and understand the potential risks before investing.
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| AI Investment Finder Use AI to screen and filter profitable investment opportunities | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets |